Diaceutics PLC Investor Relations
Investor Overview
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharma companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.
DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of labs.
Diaceutics' data capability is one of the three key value drivers it has integrated into its unique DXRX platform alongside its global lab network and product suite tailored for precision testing.
Upcoming Events
2024
Capital Markets Day
12th JunAGM
24th JunUpcoming Events
2024
Capital Markets Day
12th JunAGM
24th JunFeatured Investor News
Investor Alerts
If you would like to recieve investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.